Published on 28.03.17 in Vol 6, No 3 (2017): March
Works citing "Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer"
According to Crossref, the following articles are citing this article (DOI 10.2196/resprot.7201):
(note that this is only a small subset of citations)
-
Cortesi E, Caponnetto S, Masi G, Urbano F, Mezi S, Gelibter A, Pelle G, Filippi L, Cianni R. Efficacy and Tolerability of Selective Internal Radiotherapy With Yttrium-90 as Consolidation Treatment After Chemotherapy in Metastatic Colorectal Cancer. Clinical Colorectal Cancer 2020;19(4):e272
CrossRef -
. Selective internal radiotherapy in advanced colorectal cancer: only for right-sided tumours?. The Lancet Oncology 2017;18(9):1138
CrossRef -
Gibbs P, Heinemann V, Sharma NK, Taieb J, Ricke J, Peeters M, Findlay M, Robinson B, Jackson C, Strickland A, Gebski V, Van Buskirk M, Zhao H, van Hazel G, Brown M, Burge M, Cardaci G, Clarke S, Eliadis P, Ferguson T, Ganju V, Gibbs P, James P, Karapetis C, Liauw W, Marx G, Matos M, Nott L, Pavlakis N, Powell A, Price T, Ransom D, Segelov E, Shannon J, Singhal N, Walpole E, Craninx M, Delaunoit T, Deleporte A, Ferrante M, Geboes K, Hendlisz A, Hendrickx K, De Man M, Monsaert E, Moons V, Polus M, Boucher E, Balosso J, Chevallier P, Louafi S, Pracht M, Rebischung C, Smith D, Terrebonne E, Bruch H, Gehbauer G, Helmberger T, Ko Y, Kröning H, Lammert F, Nusch A, Pluntke S, Ridwelski K, Riera-Knorrenschild J, Riess H, Riera JR, Sauerbruch T, Scheidhauer K, Stötzer O, Tatsch K, Vehling-Kaiser U, Vogl T, Beny A, Geva R, Shacham-Shmueli E, Stemmer S, Tichler T, Wolf I, Angelelli B, Martoni A, Findlay MP, Isaacs R, O’Donnell A, Perez D, Robinson BA, Rodríguez J, Vera-Garcia R, Amin P, Bloomgarden D, Bui J, Carlisle J, Chai S, Chen Y, Chuong M, Coveler A, Facchini F, Frenette G, Frick J, Garofalo M, George B, Gordon M, Gulec S, Hannigan J, Holtzman M, Kaubisch A, Kaiser A, Kooy T, Limentani S, Margolis J, Martin R, Ozer H, Padia S, Rilling W, Savin M, Schneiderman E, Seeger G, Sharma N, Shibata S, Smith R, Wang E, Whiting S, Aghmesheh M, Burge M, Cooray P, Feeney K, Lim L, Singh M, Underhill C, Deleporte A, Durand A, Faivre S, Ferru A, Hammel P, Bremer C, De Wit M, Ayala H, Heching N, Shani A, Granetto C, Masi G, Mosconi S, Numico G, Trogu A, Kim YH, Sae-Won H, Jackson C, O'Donnell A, Fragoso M, Tan I, Casado AR, Liang JT, Liu JH, Ades S, Auber M, Boland P, Bowers C, Crain M, Dowling K, Iyer R, Ratner L, Sanchez F, Stoltzfus P, Westcott M. Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies. Clinical Colorectal Cancer 2018;17(4):e617
CrossRef -
Chakedis J, Squires MH, Beal EW, Hughes T, Lewis H, Paredes A, Al-Mansour M, Sun S, Cloyd JM, Pawlik TM. Update on current problems in colorectal liver metastasis. Current Problems in Surgery 2017;54(11):554
CrossRef -
Lee EJ, Chung HW, Jo J, So Y. Radioembolization for the Treatment of Primary and Metastatic Liver Cancers. Nuclear Medicine and Molecular Imaging 2019;53(6):367
CrossRef -
Wolstenholme J, Fusco F, Gray AM, Moschandreas J, Virdee PS, Love S, Van Hazel G, Gibbs P, Wasan HS, Sharma RA. Quality of life in the FOXFIRE, SIRFLOX and FOXFIRE‐global randomised trials of selective internal radiotherapy for metastatic colorectal cancer. International Journal of Cancer 2020;147(4):1078
CrossRef -
Spyridonidis T, Spyridonidis J, Papathanasiou N, Katsanos K. History and development of radioembolization. Nuclear Medicine Communications 2019;40(7):684
CrossRef -
Wasan HS, Gibbs P, Sharma NK, Taieb J, Heinemann V, Ricke J, Peeters M, Findlay M, Weaver A, Mills J, Wilson C, Adams R, Francis A, Moschandreas J, Virdee PS, Dutton P, Love S, Gebski V, Gray A, van Hazel G, Sharma RA, Bateman A, Blesing C, Brown E, Chau I, Cummins S, Cunningham D, Falk S, Hadaki M, Hall M, Hickish T, Hornbuckle J, Lofts F, Lowndes S, Mayer A, Metcalfe M, Middleton G, Montazeri A, Muirhead R, Polychronis A, Purcell C, Ross P, Sherwin L, Smith D, Soomal R, Swinson D, Walther A, Wasan H, Wilson G, Amin P, Angelelli B, Balosso J, Beny A, Bloomgarden D, Boucher E, Brown M, Bruch H, Bui J, Burge M, Cardaci G, Carlisle J, Chai S, Chen Y, Chevallier P, Chuong M, Clarke S, Coveler A, Craninx M, Delanoit T, Deleporte A, Eliadis P, Facchini F, Ferguson T, Ferrante M, Frenette G, Frick J, Ganju V, Garofalo M, Geboes K, Gehbauer G, George B, Geva R, Gordon M, Gregory K, Gulec S, Hannigan J, Heching N, Helmberger T, Hendlisz A, Hendrickx K, Holtzman M, Isaacs R, Jackson C, James P, Kaiser A, Karapetis C, Kaubisch A, Ko Y, Kröning H, Lammert F, Liauw W, Limentani S, Louafi S, de Man M, Margolis J, Martin R, Martoni A, Marx G, Matos M, Monsaert E, Moons V, Nott L, Nusch A, O'Donnell A, Ozer H, Padia S, Pavlakis N, Perez D, Pluntke S, Polus M, Powell A, Pracht M, Price T, Ransom D, Rebischung C, Ridwelski K, Riera-Knorrenschild J, Riess H, Rilling W, Robinson B, Rodríguez J, Sanchez F, Sauerbruch T, Savin M, Scheidhauer K, Schneiderman E, Seeger G, Segelov E, Schmueli ES, Shani A, Shannon J, Sharma N, Shibata S, Singhal N, Smith D, Smith R, Stemmer S, Stötzer O, Strickland A, Tatsch K, Terrebonne E, Tichler T, Vehling-Kaiser U, Vera-Garcia R, Vogl T, Walpole E, Wang E, Whiting S, Wolf I, Ades S, Aghmesheh M, Auber M, Ayala H, Boland P, Bouche E, Bowers C, Bremer C, Burge M, Casado AR, Cooray P, Crain M, De Wit M, Dowling K, Durand A, Faivre S, Feeney K, Ferguson T, Ferru A, Fragoso M, Granetto C, Hammel P, Issacs R, Iyer R, Kim YH, Liang JT, Lim L, Liu JH, Masi G, Mosconi S, Numico G, Ratner L, Sae-Won H, Singh M, Stoltzfus P, Tan I, Trogu A, Underhill C, Westcott M. First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials. The Lancet Oncology 2017;18(9):1159
CrossRef -
van Roekel C, Jongen JMJ, Smits MLJ, Elias SG, Koopman M, Kranenburg O, Borel Rinkes IHM, Lam MGEH. Mode of progression after radioembolization in patients with colorectal cancer liver metastases. EJNMMI Research 2020;10(1)
CrossRef -
Lloy S, Lin M, Franko J, Raman S. The Future of Interventions for Stage IV Colorectal Cancers. Clinics in Colon and Rectal Surgery 2024;37(02):114
CrossRef -
Raphael MJ, Karanicolas PJ. Regional Therapy for Colorectal Cancer Liver Metastases: Which Modality and When?. Journal of Clinical Oncology 2022;40(24):2806
CrossRef -
Sulciner ML, Clancy TE. Surgical Management of Pancreatic Neuroendocrine Tumors. Cancers 2023;15(7):2006
CrossRef
According to Crossref, the following books are citing this article (DOI 10.2196/resprot.7201):
-
Sciuto R, Rea S, Pizzi G, Vallati GE, Strigari L. Clinical Applications of Nuclear Medicine Targeted Therapy. 2018. Chapter 15:165
CrossRef -
. Cancer Regional Therapy. 2020. Chapter 3:27
CrossRef -
Spolverato G, Deipolyi AR, D’Angelica M. Cancer Regional Therapy. 2020. Chapter 28:341
CrossRef -
Karaosmanoglu AD, Onur MR, Akhan O. Textbook of Gastrointestinal Oncology. 2019. Chapter 31:551
CrossRef -
van Roekel C, Braat AJAT, Smits MLJ, Bruijnen RCG, de Keizer B, Lam MGEH. Clinical Nuclear Medicine. 2020. Chapter 36:961
CrossRef -
Chandegra B, Prajapati P, Prajapati BG. Colorectal Cancer. 2024. :95
CrossRef